PhaseBio Pharmaceuticals Inc·4

Feb 9, 4:56 PM ET

Mow Jonathan P 4

4 · PhaseBio Pharmaceuticals Inc · Filed Feb 9, 2021

Insider Transaction Report

Form 4
Period: 2021-02-05
Mow Jonathan P
DirectorChief Executive Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-02-05+234,000234,000 total
    Exercise: $4.31Exp: 2031-02-05Common Stock (234,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 5, 2021, subject to the reporting person's continued service through each such date.

Documents

1 file
  • 4
    wf-form4_161290775814589.xmlPrimary

    FORM 4